Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
170M
-
Number of holders
-
217
-
Total 13F shares, excl. options
-
121M
-
Shares change
-
+3.28M
-
Total reported value, excl. options
-
$3.49B
-
Value change
-
+$85M
-
Put/Call ratio
-
1.12
-
Number of buys
-
114
-
Number of sells
-
-106
-
Price
-
$28.84
Significant Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) as of Q4 2016
294 filings reported holding ACAD - ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value as of Q4 2016.
ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) has 217 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 121M shares
of 170M outstanding shares and own 71.18% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (25.8M shares), FMR LLC (18.2M shares), VANGUARD GROUP INC (7.12M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.66M shares), OppenheimerFunds, Inc. (4.75M shares), FRANKLIN RESOURCES INC (4.22M shares), Capital World Investors (3.5M shares), JANUS CAPITAL MANAGEMENT LLC (3.39M shares), STATE STREET CORP (3.35M shares), and WADDELL & REED FINANCIAL INC (3.09M shares).
This table shows the top 217 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.